Resources
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 46
HIV-Specific Neutralizing Antibodies by Target
A number of broadly neutralizing antibodies that target various regions of HIV’s Env protein are being developed for HIV prevention.
Prevention Option:
An Advocate’s Guide to Research in Pregnant and Lactating Populations
A resource that provides background on the need for research in pregnant and lactating populations and how advocates can advance inclusion.
Sexual and Reproductive Health Integration Advocacy Roadmap
This roadmap addresses the critical need for integrated sexual and reproductive health (SRH) and HIV services. This integration is essential for enhancing public health outcomes, socio-economic benefits, and individual health and rights. The Roadmap aims to revitalize and sustain advocacy efforts for SRH and HIV integration, empower communities to hold stakeholders accountable for implementation, increase political and program support to enable the shift from policy to practice, and foster dynamic partnerships across research, advocacy, implementation, and policy sectors.
It was developed by Copper Rose Zambia (CRZ) as part of the Coalition to Accelerate and Support Prevention Research (CASPR). It draws on extensive input, including desk reviews, interviews, focus group discussions, and a specialized workshop held at the 2023 International Conference on AIDS and STIs in Africa (ICASA).
Prevention Option:
PxPulse: The Advocacy Chronicles with APHA’s Yvette Raphael
Our debut episode of the Advocacy Chronicles features Yvette Raphael, the Executive Director of Advocacy for Prevention of HIV and AIDS (APHA) in South Africa, and a leader in the development of The Choice Manifesto.
CASPR Results Bulletin
In this issue — what the MERL Roadshow is all about, inspiring work from CASPR partners, the HIV Prevention Choice Manifesto, and what’s in store for 2024.
From the Lab to the Jab
From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.
Prevention Option:
Local Vaccine Production: Harnessing Its Potential for Equity
This issue brief on local vaccine production covers the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.
Prevention Option:
mRNA Technology: What It Might Mean for Future Vaccines
This issue brief on mRNA technology covers what it is, how it works, current knowledge gaps and ideas for advocacy to harness its potential.
Prevention Option:
Vaccine Access: What’s Working and What’s Next
This issue brief covers the web of issues that influence access to vaccines.
Prevention Option:
Vaccine Research and Development: Key Lessons and Ways Forward
This issue brief on the vaccine research and development (R&D) process is one of a series of four briefs.
Prevention Option:
showing 1-10 of 46